About the Job
The internship will focus on our in vitro diagnostics development work in endometriosis and will involve the following responsibilities: writing research grant proposals, developing project plans, supporting the design and prototyping of our IVD assay, creating technical and scientific documents, defining processes within the product development cycle, outreach to clinical and industry partners to establish international collaborations.
We will provide training in quality management, clinical discovery and product development. The intern will be given the opportunity to work on diverse tasks that have a real impact on healthcare. We offer a hybrid work setup (combination of office-based and remote work).
We are looking for self-motivated, creative and independent people who are keen to see the immediate impact of their work and bring their ideas to life. If you are excited by the possibility of being part of a young startup and making an impact on healthcare, please send your application now!
Required skills and experience:
- excellent writing and presenting skills
- process-oriented
- interest in building relationships
- very good interpersonal skills
- self-motivated, flexible
- Very good English (oral & written)
- German would be an asset
- Master’s degree or PhD in Life Sciences or Engineering
- Allowed to work in Switzerland (Swiss/EU citizen and/or having a valid work permit)
Please send your application, including your cover letter and your CV (in English) to careers@scailyte.com
Call for applications open until Jul 31st, 2022
Starting date: 15th August, 2022
About Scailyte
Scailyte is a globally recognized spin-off from ETH Zürich and pioneer in the field of single-cell data analysis (Nature Spinoff Award, Forbes Top30 in AI, Masschallenge winner, Swiss Top100 Startups). Scailyte’s mission is to discover and develop biomarkers for precision medicine using single-cell data and Artificial Intelligence. Our pioneering technology integrates multimodal single-cell and clinical data to identify novel disease signatures. We are providing innovative solutions for rapid discovery of ultra-sensitive biomarkers for customers in pharma, biotech and clinical research. We are a multidisciplinary multinational team of highly skilled and enthusiastic professionals, offering an inspiring and open-minded environment for career growth. Check out our company video and what our employees say about working at Scailyte: Scailyte Youtube channel.
Recent News
Scailyte Extends Series A to USD 8 Million
We are thrilled to announce the extension of our Series A funding, bringing the total raised amount ...
Recent News
ScaiDigest Volume 6: Variational autoencoders (VAEs) in biology
Welcome to the 6th edition of ScaiDigest, where we explore cutting-edge research in single-cell anal...
Recent News
Pitch-nic Expo
We're excited to share that our Senior Vice President of Corporate & Technology Development, Corinne...
Recent News
Targets & Cell Types in Immuno-Oncology Europe 2023
Scailyte is part of Targets & Cell Types in Immuno-Oncology Europe 2023 event on November 14-15 in B...
Recent News
Unravelling the AI Executive Order: A Discussion with Our CEO and Head of Regulatory Affairs
We invite you to watch this enlightening discussion to gain valuable insights into the evolving AI l...
Recent News
NextGen Omics 2023
Scailyte is gearing up for NextGen Omics 2023, one of the most scientifically engaging events in Lon...
Recent News
Recent News
ScaiDigest Volume 5: Unlocking the Secrets of AML
Read Diana's insightful post and stay at the forefront of scientific advancements in the field!
Recent News
Scailyte Extends Series A to USD 8 Million
We are thrilled to announce the extension of our Series A funding, bringing the total raised amount ...
ScaiDigest Volume 6: Variational autoencoders (VAEs) in biology
Welcome to the 6th edition of ScaiDigest, where we explore cutting-edge research in single-cell anal...
Recent News
Pitch-nic Expo
We're excited to share that our Senior Vice President of Corporate & Technology Development, Corinne...
Targets & Cell Types in Immuno-Oncology Europe 2023
Scailyte is part of Targets & Cell Types in Immuno-Oncology Europe 2023 event on November 14-15 in B...
Recent News
Unravelling the AI Executive Order: A Discussion with Our CEO and Head of Regulatory Affairs
We invite you to watch this enlightening discussion to gain valuable insights into the evolving AI l...
NextGen Omics 2023
Scailyte is gearing up for NextGen Omics 2023, one of the most scientifically engaging events in Lon...
Recent News
SITC 2023
Diana Stoycheva and Julian Spagnuolo will be sharing Scailyte’s science at a poster #201, and will...
ScaiDigest Volume 5: Unlocking the Secrets of AML
Read Diana's insightful post and stay at the forefront of scientific advancements in the field!